Dyslipidemia and ischemic heart disease mortality among men and women with diabetes

Circulation

Volumn 89, Issue 3, 1994, Pages 991-997

  Goldschmid, Merilyn G ^a   Barrett Connor, Elizabeth ^b   Edelstein, Sharon L ^b   Wingard, Deborah L ^b   Cohn, Barbara A ^c   Herman, William H ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Comb Ctr Res Women's C ^*  (United States)

Author keywords

diabetes mellitus; ischemia; lipoproteins; mortality

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 0028330030     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.3.991     Document Type: Article

References (36)

1. Wingard DL. The sex differential in morbidity, mortality, and lifestyle. Annu Rev Public Health. 1984;5:433-458.
2. Barrett-Connor E, Orchard T. Diabetes and heart disease. In: Harris MI, Hamman RF, eds. Diabetes in America. Bethesda, Md: National Institutes of Health; 1985:1-41. NIH publiation 85-1468.
3. Pyorala K, Laakso M. Macrovascular disease in diabetes mellitus. In: Mann JI, Pyorala K, Teuscher A, eds. Diabetes in Epidemiological Perspective. New York, NY: Churchill Livingstone Inc; 1983: 183-264.
4. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive hormone use of estrogen in women: results from the Lipid Research Clinics' follow-up study. Circulation. 1987;75:1102-1109.
5. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics' follow-up study. Am J Epidemiol. 1987;126:629-637.
6. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med. 1971;74:1-12.
7. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Cawber TR. High density lipoproteins: a protective factor against coronary heart disease. Am J Med. 1977;62:707-711.
8. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death. Arch Intern Med. 1981;141: 1128-1131.
9. Kannel WB. High density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am J Cardiol. 1983;52:96-126.
10. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383-390.
11. Castelli WP, Doyle JT, Gordon T, Haines CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation. 1977;55:767-772.
12. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J. 1987;114:413-419.
13. Waiden CE, Knopp RH, Wahl PW, Beach KW, Strandness E Jr. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med. 1984; 311:953-959.
14. Wingard DL, Barrett-Connor E, Criqui MH, Suarez L. Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol. 1983;117:19-26.
15. Bierman EL, Bagdade JD, Porte D Jr. A concept of the pathogenesis of diabetic lipemia. Trans Assoc Am Physicians. 1966;79:348-360.
16. Barrett-Connor E, Witzum JL, Holdbrook M. A community study of high density lipoproteins in adult non-insulin dependent diabetics. Am J Epidemiol. 1983;117:186-192.
17. Criqui M, Barrett-Connor E, Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol. 1978;108:367-372.
18. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol. 1980;111:705-712.
19. Central Patient Registry and Coordinating Center for the Lipid Research Clinics. Reference Manual for the Lipid Research Clinics Program Prevalence Study. Chapel Hill, NC: University of North Carolina, Department of Biostatistics; 1974; 1,2.
20. Lipid Research Clinics Program. Manual of Laboratory Operations, I. Lipid and Lipoprotein Analysis. Washington, DC: United States Government Printing Office, 1974. US Dept of Health, Education, and Welfare publication NIH 75-628.
21. The International Classification of Diseases, Ninth Revision, Clinical Modification: ICD-9-CM. 2nd ed. Washington, DC: US Dept of Health and Human Services, Public Health Service; 1980.
22. Emerson JD, Strenio J. Boxplots and batch comparison. In: Hoaglin DC, Mosteller F, Tukey JW, eds. Understanding Robust and Exploratory Data Analysis. New York, NY: John Wiley & Sons, Inc; 1983.
23. Cox DR. Regression models and life tables (with discussion). J R Stat Soc. 1972;8:187-220.
24. SAS Institute Inc. SAS Language and Procedures: Usage 2, Version 6. Cary, NC: SAS Institute Inc; 1991.
25. Feskens EJM, Bowles CH, Kromhout K. Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol. 1991;44:947-953.
26. Blunt BA, Barrett-Connor E, Wingard DL. Evaluation of fasting plasma glucose as screening test for NIDDM in older adults. Diabetes Care. 1991;14:989-993.
27. Agardh C-D, Sartor G, Nilsson-Ehle P. Plasma high density lipoproteins and lipolytic enzyme activities in diabetic patients. Acta Med Scand. 1983;213:123-128.
28. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol. 1988;128:389-401.
29. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986;123:504-516.
30. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: the WHO multinational study of vascular disease in diabetics. Diabetologia. 1985;28:615-640.
31. Laakso M, Lehto S, Penttilä I. Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 1993; 88:1421-1430.
32. Orchard TJ. Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am. 1990;19:361-380.
33. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987;28:613-628.
34. Biesbroeck RC, Albers JJ, Wahl PW, Weinberg CR, Bassett ML, Bierman EL. Abnormal composition of high density lipoproteins in non-insulin dependent diabetics. Diabetes. 1982;31:126-131.
35. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
36. Modan M, Or J, Karasik A, Drory Y, Fuchs Z, Lusky A, Chetrit A, Halkin H. Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation. 1991;84:1165-1175.